| scholarly article | Q13442814 |
| P2093 | author name string | Weidler DJ | |
| Jallad NS | |||
| Baez MA | |||
| Garg DC | |||
| P2860 | cites work | Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man | Q42116080 |
| A pharmacodynamic and pharmacokinetic assessment of a new alpha- adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects | Q43241370 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 63S-67S | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol | |
| P478 | volume | 21 Suppl 1 |
| Q37608000 | Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism |
| Q36332217 | Alpha1-adrenergic blockers: current usage considerations |
| Q24201322 | Blood pressure lowering efficacy of alpha blockers for primary hypertension |
| Q24240127 | Blood pressure lowering efficacy of alpha blockers for primary hypertension |
| Q24186037 | Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension |
| Q34397966 | Concentration-effect relationships and individual responses to doxazosin in essential hypertension |
| Q39469038 | Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension |
| Q38367793 | Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists |
| Q46967783 | Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure |
Search more.